BioSpace News Archive

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that BALVERSA™ (erdafitinib) received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adults with locally advanced or metastatic urothelial carcinoma (mUC)

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will provide remarks at the Canadian Conference on Medical Education.

Activision Blizzard is now facing scrutiny after it was discovered the company paid pregnant employees for access to the data from their Ovia Health app.

QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced the U.S. launch of its novel therascreen® FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a companion diagnostic to help guide the use of the newly approved FGFR kinase inhibitor, BALVERSA™ (erdafitinib), developed by Janssen Biotech, Inc. (Janssen).

With the passing of Senate Bill 220 during the Ohio 132nd General Assembly and the signature of Governor Kasich into law, Ohio is positioned as a national policy leader on the use of Blockchain technology

Caitlin was recognized for her compassion and support of the families she works with

CHG Healthcare, the nation’s largest privately held healthcare staffing company, has named Kevin Ricklefs chief culture officer.

78 Presentations by Coalition Members During the Annual Meeting

SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their procurement market intelligence engagement for a pharmaceutical company.

American Forensics has achieved accreditation by the ANAB/ANSI National Accreditation Board in the Field of Forensic Science Inspection in the discipline of Medical Legal Death Investigation.